Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000632362 | SCV000753540 | likely benign | Neurofibromatosis, type 1 | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431868 | SCV001189223 | benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-01-10 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001026778 | SCV002528120 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-02-13 | criteria provided, single submitter | curation | |
Genome- |
RCV000632362 | SCV002561136 | uncertain significance | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003129952 | SCV003815868 | uncertain significance | not provided | 2021-08-02 | criteria provided, single submitter | clinical testing |